REVB
NASDAQ · Biotechnology
Revelation Biosciences Inc
$4.27
-0.12 (-2.63%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+139.4% upside
Low Target
$7.91
Average Target
$10.21
High Target
$15.75
Current Price
$4.27
Current
$4.27
$4.27
Target
$10.21
$10.21
$7.91
$10.21 avg
$15.75
Scenario Analysis
Bear Case
$7.91
85.5%
Low target
Base Case
$10.21
+139.4%
Avg target
Bull Case
$15.75
+269.3%
High target
Risk/Reward
3.2x
Highly favorable
Price in Context
52-Week High
$40.60
-89.5% from high
52-Week Low
$3.08
+38.5% from low
Target vs 52W High
$10.21
-74.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.7% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.8% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.6% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| MRNA | Hold | 31 | 32% | $149.45 | -33.1% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.2% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -33.8% |